raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:183660

Severe combined immunodeficiency

Synonyms: SCID

Type
Clinical group
Group
Group of disorders
Inheritance
Autosomal recessive, X-linked recessive
Age of onset
Infancy, Neonatal
Status
active

Severe combined immunodeficiency (SCID) comprises a group of rare monogenic primary immunodeficiency disorders characterized by a lack of functional peripheral T lymphocytes resulting in early-onset severe respiratory infections and failure to thrive. They are classified according to immunological phenotype into SCID with absence of T cells but presence of B cells (T-B+ SCID) or SCID with absence of both (T-B- SCID). Both of these groups include several forms, with or without natural killer (NK) cells.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enSevere combined immunodeficiencySCID
frDéficit immunitaire combiné sévèreIDCS · Immunodéficience combinée sévère · SCID
deImmundefekt, kombinierter schwerer= en
esInmunodeficiencia combinada graveIDCG · SCID
itImmunodeficienza combinata grave
nlErnstige gecombineerde immuundeficiëntie= en
ptImunodeficiência combinada grave
plCiężki złożony Niedobór odporności= en
csTěžká kombinovaná imunodeficience= en
ukТяжкий комбінований імунодефіцит= en
zh重症联合免疫缺陷= en
trAğır kombine immün yetmezlik= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-114A01.10Especificvalidated
MONDO0015974Evalidated
MONDO15974Evalidated
MeSHD016511Evalidated
UMLSC0085110Evalidated
GARD7628Evalidated
MedDRA10069566Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

Children (2):

Codes that Orphanet moved or referred to this one:

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

9 records
TypeClassValueAreaQualificationValidationSource
Prevalence at birth1-9 / 100 0001.65 / 100 000EuropeValue and classValidated[EXPERT]_ORPHANET
Prevalence at birth1-9 / 100 0001.6 / 100 000FranceValue and classValidated22288591[PMID]
Prevalence at birth1-9 / 100 0001.7 / 100 000GreeceValue and classValidated21732012[PMID]
Prevalence at birth1-9 / 100 0001.75 / 100 000AustraliaValue and classNot yet validated18221464[PMID]_9314356[PMID]_ ORPHANET
Prevalence at birth1-9 / 100 0001.28 / 100 000ChileValue and classValidated17191150[PMID]
Prevalence at birth1-9 / 100 0003.79 / 100 000Costa ricaValue and classValidated17191150[PMID]
Point prevalenceUnknown—WorldwideClass onlyNot yet validatedORPHANET
Prevalence at birth1-9 / 100 0001.72 / 100 000United StatesValue and classValidated25138334[PMID]
Prevalence at birth1-9 / 100 000—WorldwideClass onlyNot yet validatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card